| Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo SP Cobbold, A Jayasuriya, A Nash, TD Prospero, H Waldmann Nature 312 (5994), 548-551, 1984 | 1080 | 1984 |
| " Infectious" transplantation tolerance S Qin, SP Cobbold, H Pope, J Elliott, D Kioussis, J Davies, H Waldmann Science 259 (5097), 974-977, 1993 | 1043 | 1993 |
| Identification of regulatory T cells in tolerated allografts L Graca, SP Cobbold, H Waldmann The Journal of experimental medicine 195 (12), 1641-1646, 2002 | 711 | 2002 |
| Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants SP Cobbold, R Castejon, E Adams, D Zelenika, L Graca, S Humm, ... The journal of immunology 172 (10), 6003-6010, 2004 | 529 | 2004 |
| Both CD4+ CD25+ and CD4+ CD25− regulatory cells mediate dominant transplantation tolerance L Graca, S Thompson, CY Lin, E Adams, SP Cobbold, H Waldmann The Journal of Immunology 168 (11), 5558-5565, 2002 | 472 | 2002 |
| Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells M Tone, Y Tone, E Adams, SF Yates, MR Frewin, SP Cobbold, ... Proceedings of the National Academy of Sciences 100 (25), 15059-15064, 2003 | 454 | 2003 |
| Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance SP Cobbold, G Martin, S Qin, H Waldmann Nature 323 (6084), 164-166, 1986 | 451 | 1986 |
| Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells I Müller, SP Cobbold, H Waldmann, SH Kaufmann Infection and immunity 55 (9), 2037-2041, 1987 | 425 | 1987 |
| Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2, 3 dioxygenase AL Mellor, P Chandler, B Baban, AM Hansen, B Marshall, J Pihkala, ... International immunology 16 (10), 1391-1401, 2004 | 387 | 2004 |
| Humanised monoclonal antibody therapy for rheumatoid arthritis JD Isaacs, G Hale, SP Cobbold, H Waldmann, RA Watts, BL Hazleman, ... The Lancet 340 (8822), 748-752, 1992 | 384 | 1992 |
| Induction of classical transplantation tolerance in the adult. SX Qin, S Cobbold, R Benjamin, H Waldmann The Journal of experimental medicine 169 (3), 779-794, 1989 | 383 | 1989 |
| Infectious tolerance via the consumption of essential amino acids and mTOR signaling SP Cobbold, E Adams, CA Farquhar, KF Nolan, D Howie, KO Lui, ... Proceedings of the National Academy of Sciences 106 (29), 12055-12060, 2009 | 360 | 2009 |
| Induction of tolerance in peripheral T cells with monoclonal antibodies S Qin, M Wise, SP Cobbold, L Leong, YC M. Kong, JR Parnes, ... European journal of immunology 20 (12), 2737-2745, 1990 | 325 | 1990 |
| Infectious tolerance S Cobbold, H Waldmann Current opinion in immunology 10 (5), 518-524, 1998 | 316 | 1998 |
| CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression K Honey, SP Cobbold, H Waldmann The Journal of Immunology 163 (9), 4805-4810, 1999 | 303 | 1999 |
| Monoclonal-antibody therapy in systemic vasculitis PW Mathieson, SP Cobbold, G Hale, MR Clark, DBG Oliveira, ... New England Journal of Medicine 323 (4), 250-254, 1990 | 300 | 1990 |
| Regulating the immune response to transplants: a role for CD4+ regulatory cells? H Waldmann, S Cobbold Immunity 14 (4), 399-406, 2001 | 294 | 2001 |
| Different Roles for L3T4+ and Lyt 2+ T Cell Subsets in the Control of an Acute Herpes Simplex Virus Infection of the Skin and Nervous System AA Nash, A Jayasuriya, J Phelan, SP Cobbold, H Waldmann, T Prospero Journal of General Virology 68 (3), 825-833, 1987 | 289 | 1987 |
| Functional analysis of T lymphocyte subsets in antiviral host defense. TP Leist, SP Cobbold, H Waldmann, M Aguet, RM Zinkernagel Journal of immunology (Baltimore, Md.: 1950) 138 (7), 2278-2281, 1987 | 280 | 1987 |
| Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW) S Cobbold, SU Metcalfe Tissue antigens 43 (3), 137-154, 1994 | 272 | 1994 |
Luis GracaIMM, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de LisboaEmail verificata su fm.ul.pt